Heartflow, Inc. (HTFL) stock
HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30453% above fair value
$45.89−1.18 (-2.51%)
Close on Nov 18, 2026Market cap $3.99BP/E –Yield –
Heartflow free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Heartflow's free cash flow for the twelve months ending Jun 30, 2026 was -$59.18M. For fiscal 2025 it was -$59.05M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$59.05M | – |
| FY2024 | Dec 31, 2024 | -$73.36M | – |
| FY2023 | Dec 31, 2023 | -$82.54M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.50M | – |
| Q1 FY2026 | Mar 31, 2026 | -$31.99M | – |
| Q4 FY2025 | Dec 31, 2025 | -$12.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.19M | – |
| Q2 FY2025 | Jun 30, 2025 | -$28.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.27M | – |
| Q4 FY2024 | Dec 31, 2024 | -$14.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.29M | – |
See a number that looks wrong?